Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Shannon K Oda

Assistant Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (9)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (9)

Daniel Chen

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Heather Gustafson

Assistant Professor

University of Washington

UNITED STATES

View details

David Koelle

Professor

University of Washington

UNITED STATES

View details

Raphael Gottardo

University of Lausanne

SWITZERLAND

View details

Aude Chapuis

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Evan Hall

Assistant Professor

University of Washington

UNITED STATES

View details

Cecilia Yeung

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Paul Nghiem

Professor

University of Washington

UNITED STATES

View details

Shailender Bhatia

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shannon K Oda

Research Interests

Explore related searches

Articles (9)

Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma

A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands

CD40L and FLT3L fusion proteins in engineered T cells drive myeloid reprogramming and durable antitumor immunity

CD40L-HVEM dual costimulatory receptor-T cells promote endogenous macrophage reprogramming and increased therapeutic efficacy against AML

Preclinical efficacy of combinatorial B7-H3 CAR T cell and ONC206 treatment in DIPG/DMG

Developing Novel Cell Therapy Strategies to Convert Macrophage Programming and Induce Synergistic, Multicellular Immunity Against AML

Engineering Synergistic Adoptive Cell Therapies for Enhanced Treatment of Acute Myeloid Leukemia

Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma

TGF-β broadly modifies rather than specifically suppresses reactivated memory CD8 T cells in a dose-dependent manner

Collaborators (9)

Daniel Chen

Heather Gustafson

David Koelle

Raphael Gottardo

Aude Chapuis

Evan Hall

Cecilia Yeung

Paul Nghiem

Shailender Bhatia

Make your next move.